Question 1

What is the catalog number for 2- (3-Nitro-1H-pyrazol-1-yl) cyclohexan-1-one?

Accepted Answer

The catalog number for 2- (3-Nitro-1H-pyrazol-1-yl) cyclohexan-1-one is JFC58216.

Question 2

What sizes are available for 2- (3-Nitro-1H-pyrazol-1-yl) cyclohexan-1-one?

Accepted Answer

2- (3-Nitro-1H-pyrazol-1-yl) cyclohexan-1-one is available in the following size(s): 50 mg, 0.5 g.

Question 3

How many pack sizes does 2- (3-Nitro-1H-pyrazol-1-yl) cyclohexan-1-one come in?

Accepted Answer

2- (3-Nitro-1H-pyrazol-1-yl) cyclohexan-1-one is available in 2 different pack sizes.

Question 4

Is 2- (3-Nitro-1H-pyrazol-1-yl) cyclohexan-1-one in stock?

Accepted Answer

2- (3-Nitro-1H-pyrazol-1-yl) cyclohexan-1-one is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 6

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 7

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

2- (3-Nitro-1H-pyrazol-1-yl) cyclohexan-1-one

Product Specifications

CAS Number

MDL Number

Smiles

Molecular Formula

Molecular Weight

Controlled

Available Sizes

Frequently Asked Questions

Explore Other Products

3Alpha-Phenylacetoxy Tropane-d5

Mouse IgG3 (Fcγ Fragment specific), AlpSdAbs® VHH (HRP)

LST1 (NM_205839) Human Recombinant Protein

Tissue FFPE Sections, Ovary

Alkaline Phosphatase Conjugate Stabilizer, 1X

Anti-GAPDH Antibody [12D6]